Thailand’s Food and Drug Administration (Thai FDA) has approved the use of a High Flow Oxygen Therapy (HFOT) system developed by US-based respiratory care company Telesair.
The Health Ministry disbursed financial assistance to 150 regional general hospitals (RSUD) and 25 central general hospitals (RSUP) to improve services for .
Vaishanavi Kumbalwar, Senior Associate Content Writer, Allied Market Research gives an insight on how partnerships, innovations are key for therapeutic respiratory devices development
Vaishanavi Kumbalwar, Senior Associate Content Writer, Allied Market Research gives an insight on how partnerships, innovations are key for therapeutic respiratory devices development
The use of high-flow oxygen through a nasal cannula is better than conventional oxygen therapy in severe Covid-19, according to a recent study published in the JAMA Network. The effect of.